[1]
U. Saxena, A. Nischal, A. Nischal, A. A. Mahdi, M. Agarwal, and A. Tripathi, “Clinical efficacy and safety of lurasidone in schizophrenia: 8 week randomized double blind active controlled trial”, Int J Adv Med, vol. 7, no. 5, pp. 817–824, Apr. 2020.